-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
*For medical professionals only
summary
(Swipe up or down to see all)
ObjectiveTo evaluate the safety and efficacy
Methods: From November 2017 to November 2018, 400 patients with acute IS admitted to nine hospitals, including the Second Affiliated Hospital of Hebei Medical University, were selected as the study subjects, and on the basis of conventional treatment, 203 cases were divided into experimental group (compound astripeptide injection + conventional treatment), 85 cases in the control group (other gangliosides + conventional treatment) and 112 cases in the blank group (conventional treatment)
Results: After treatment, the apparent efficiency rates of the experimental group, the control group and the blank group were 84.
Conclusion: Compound astryptide injection is safe and effective
Stroke is the number one lethal disease in our country [1].
Neurology Branch of Chinese Medical Association, Cerebrovascular Disease Group of Neurology Branch of Chinese Medical Association.
Guidelines for the diagnosis and treatment of acute ischemic stroke in China 2018[J].
Chin J Neurology, 2018, 51(9): 666-682.
Chinese MedicalAssociationNeurologyBranch,Chi- nese Medical Association Neurology Branch Cerebro- vascular Disease Group.
Chinese acute ischemic stroke
diagnosis and treatment guide 2018 [J].
Chin J Neurol, 2018, 51(9): 666-682.
[5] Masserini M, Pitto M, Ferraretto A, et al.
Glycolip in- ter action in the mechanism of signal transduction stud- ies with a activable ganglioside analogue [J].
Acta Bio- chim Pol, 1998, 45: 393-401.
[6] Mahadik SP, Makar TK, Murthy JN, et al.
Temporal changes in super-oxide dismutase glutathione peroxi- dase,and catalase levels in primary and peri-ischemic tis- sue monosialoganglioside (GM1) treatment effects [J].
Mol Chem Neuropathol, 1993, 18(1-2): 1-14.
[7] Jauch EC, Saver JL, Adams HP, et al.
Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart A ssociation/ American Stroke Associ- ation [J].
Stroke, 2013, 44(3): 870-947.
Sun Ming, Jiang Yongning, Tian Weina .
Effect of compound aspergide injection on microcirculation and platelet aggregation in patients with cerebral infarction[J].
PLA Journal of Preventive Medicine, 2019, 37(11): 20-21.
Sun M, Jiang YN, Tian WN.
Effect of compound treo- tide injection on microcirculation and platelet aggrega- tion in patients with cerebral infarction [J].
Journal of Preventive Medicine of Chinese People's Liberation Ar- my, 2019, 37(11): 20-21.
[9] Bai Jinjuan, Tian Long, Zhang Hongli .
Clinical study of compound astripeptide injection combined with fibrin in the treatment of acute cerebral infarction[J].
Modern Pharmaceuticals and Clinical Medicines , 2020, 35(2): 247-251.
Bai JJ, Tian L, Zhang HL.
Clinical study on Com- pound and Poreine Cerebroside Injection combined with defibrase in treatment of acute cerebral infarction [J].
Drugs Clin, 2020, 35(2): 247-251.
Zhou Changkui, Wu Xiaohua .
Recent advances in clinical research on troxerutin[J].
Chinese Journal of Biochemical Drugs, 2005, 26(5): 317-319.
Zhou CK, Wu XH.
Advances in Troxerutin clinical re- search [J].
Chin J Biochem Pharm, 2005, 26(5): 317-319.
[11] Lei Shouping, Sun Xiaohua, Chen Caihua .
Effect of troxerutin brain protein hydrolysate on nerve function and quality of life in patients with acute cerebral infarction[J].
Journal of Clinical Pharmaceutical Literature, 2014, 1(8): 1325-1326.
Lei SP, Sun XH, Chen CH.
Effects of troxerutin cere- broprotein hydrolysate on neurological function and quality of life in patients with acute cerebral infarction [J].
J Clin Med, 2014, 1(8): 1325-1326.
[12] Belcaro G, Errichi BM, Laurora G, et al.
Treatment of acute superficial thrombosis and follow-up by comput- erized thermography [J].
Vasa, 1989, 18(3):227-234.
[13] GBD 2016 Causes of Death Collaborators.
Global, re- gional, and national age-sex specific mortality for 264 causes of death, 1980-2016: A systematic analysis for the global burden of disease study 2016 [J].
Lancet, 2017, 390(10100): 1151-1210.
[14] National Health Commission .
2018 China Health Statistics Compendium[M].
Beijing: Peking Union Medical College Press, 2018.
National Health Commission of the People's Republic of China.
2018 China Health Statistics Abstract [M].
Beijing: Peking Union Medical College Press, 2018.
[15] Guo X, Geng M, Du G.
Glucose transporter 1, distri- bution in the brain and in neural disorders: Its relation- ship with transport of neuroactive drugs through the blood-brain barrier [J].
Biochem Genet, 2005, 43(3/4): 175-187.
[16] Sui RB, Zang L, Bai YJ.
Administration of troxerutin and cerebroprotein hydrolysate injection alleviates cere- bral ischemia/reperfusion injury by down-regulating cas- pase molecules [J].
Neuropsychiatr Dis Treat, 2019, 15: 2345-2352.
[17] Schnaar RL, Gerardy-Schahn R, Hildebrandt H.
Sialic acids in the brain: Gangliosides and polysialic acid in ner- vous system development, stability, disease, and re- generation [J].
Physiol Rev, 2014, 94: 461-518.
[18]
LI Jianjun, SUN Qi, CAO Hui, et al.
Cerebral protective effect of gangliosides on cerebral ischemia and reperfusion injury in rats[J].
Journal of Clinical Neurology, 2006, 19(2): 124-126.
Li JJ, Sun Q, Cao H, et al.
Neuroprotective effect of Gangliosides on cerebral ischamia reperfusion injury in rats [J].
J Clin Neurol, 2006, 19(2): 124-126.
Zhong Dong, Tang Wenyuan.
Neuroelectrophysiology of gangliosides in the treatment of acute brain trauma[J].
Chinese Journal of Trauma, 1999, 15(6): 346.
Zhong D, Tang WY.
Neuroelectrophysiological study of GM1 Ganglioside in the treatment of moderate and severe head injuries [J].
Chin J Traumatol, 1999, 15 (6): 346.
[20] Ma WB, Wang SX, Liu XL, et al.
Protective effect of troxerutin and cerebroprotein hydrolysate injection on cerebral ischemia through inhibition of oxidative stress and promotion of angiogenesis in rats [J].
Mol Med Rep, 2019, 19: 3148-3158.
org.
cn
